X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (52) 52
index medicus (50) 50
male (49) 49
humans (48) 48
female (29) 29
azocines - therapeutic use (26) 26
varenicline (24) 24
smoking cessation - methods (23) 23
azocines - pharmacology (22) 22
rats (22) 22
alkaloids - therapeutic use (21) 21
alkaloids - pharmacology (20) 20
quinolizines - therapeutic use (20) 20
cytisine (19) 19
environmental sciences (19) 19
nicotine (19) 19
pharmacology & pharmacy (19) 19
azocines (18) 18
adult (17) 17
dose-response relationship, drug (17) 17
explosives (17) 17
nicotine - antagonists & inhibitors (17) 17
neurosciences (16) 16
quinolizines (16) 16
azocines - adverse effects (15) 15
azocines - toxicity (15) 15
quinolizines - pharmacology (15) 15
smoking cessation (15) 15
toxicology (15) 15
hmx (14) 14
rdx (14) 14
mice (13) 13
receptors, nicotinic - metabolism (13) 13
azocines - administration & dosage (12) 12
biodegradation (12) 12
nicotinic agonists - pharmacology (12) 12
nicotinic agonists - therapeutic use (12) 12
research (12) 12
smoking (12) 12
sustained-release bupropion (12) 12
2,4,6-trinitrotoluene (11) 11
azocines - metabolism (11) 11
benzazepines - therapeutic use (11) 11
nicotine - pharmacology (11) 11
placebo-controlled trial (11) 11
smoking-cessation (11) 11
alkaloids - adverse effects (10) 10
azocines - chemistry (10) 10
medicine, general & internal (10) 10
middle aged (10) 10
quinoxalines - therapeutic use (10) 10
azocines - pharmacokinetics (9) 9
double-blind (9) 9
nicotine - adverse effects (9) 9
psychiatry (9) 9
smoking - drug therapy (9) 9
alkaloids - administration & dosage (8) 8
analysis (8) 8
bupropion - therapeutic use (8) 8
clinical trials as topic (8) 8
explosive agents - toxicity (8) 8
hexahydro-1,3,5-trinitro-1,3,5-triazine (8) 8
octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (8) 8
pregnancy (8) 8
quinolizines - adverse effects (8) 8
randomized controlled trials as topic (8) 8
rats, wistar (8) 8
time factors (8) 8
alkaloids - metabolism (7) 7
biodegradation, environmental (7) 7
biotransformation (7) 7
efficacy (7) 7
fate (7) 7
quinolizines - administration & dosage (7) 7
randomized controlled-trial (7) 7
rats, sprague-dawley (7) 7
receptor partial agonist (7) 7
receptors, nicotinic - drug effects (7) 7
rodents (7) 7
soil pollutants - toxicity (7) 7
treatment outcome (7) 7
triazines - metabolism (7) 7
triazines - toxicity (7) 7
acetylcholine-receptors (6) 6
aged (6) 6
alkaloids (6) 6
alkaloids [therapeutic use] (6) 6
alpha-4-beta-2 (6) 6
azocines [therapeutic use] (6) 6
cessation (6) 6
heterocyclic compounds, 1-ring - toxicity (6) 6
metabolism (6) 6
nicotinic agonists - adverse effects (6) 6
quinolizines [therapeutic use] (6) 6
soil (6) 6
substance withdrawal syndrome - prevention & control (6) 6
tobacco use disorder - drug therapy (6) 6
toxicity (6) 6
alzheimers-disease (5) 5
anaerobiosis (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5, p. CD006103
Background Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract... 
Smoking [drug therapy] | Varenicline | Humans | RANDOMIZED CONTROLLED-TRIAL | Quinolizines [therapeutic use] | PSYCHIATRIC ADVERSE EVENTS | TOBACCO-DEPENDENCE TREATMENT | Quinoxalines [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Bupropion [therapeutic use] | Nicotine [adverse effects; antagonists & inhibitors] | REPLACEMENT THERAPY | SUSTAINED-RELEASE BUPROPION | Smoking Cessation [methods] | Counseling [methods] | VARENICLINE TREATMENT | METHADONE-MAINTAINED SMOKERS | Randomized Controlled Trials as Topic | Azepines [therapeutic use] | DOUBLE-BLIND PLACEBO | Alkaloids [therapeutic use] | Nicotinic Agonists [adverse effects; therapeutic use] | Azocines [therapeutic use] | LONG-TERM SAFETY | Benzazepines [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Substance Withdrawal Syndrome [prevention & control] | Heterocyclic Compounds with 4 or More Rings [therapeutic use] | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 4, Issue 4, p. CD006103
Journal Article
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2015, Volume 75, Issue 4, pp. 851 - 859
Journal Article
Journal Article
Thorax, ISSN 0040-6376, 11/2013, Volume 68, Issue 11, pp. 1037 - 1042
Journal Article
Journal Article